Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Chalmers JD"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 33
Tytuł:
Dipeptidyl peptidase-1 inhibition with brensocatib reduces the activity of all major neutrophil serine proteases in patients with bronchiectasis: results from the WILLOW trial.
Autorzy:
Cipolla D; Insmed Incorporated, 700 US Highway 202/206, Bridgewater, NJ, 08807, USA. .
Zhang J; Insmed Incorporated, 700 US Highway 202/206, Bridgewater, NJ, 08807, USA.
Korkmaz B; INSERM UMR-1100, 'Research Center for Respiratory Diseases' and University of Tours, Tours, France.
Chalmers JD; Division of Molecular and Clinical Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee, UK.
Basso J; Insmed Incorporated, 700 US Highway 202/206, Bridgewater, NJ, 08807, USA.
Lasala D; Insmed Incorporated, 700 US Highway 202/206, Bridgewater, NJ, 08807, USA.
Fernandez C; Insmed Incorporated, 700 US Highway 202/206, Bridgewater, NJ, 08807, USA.
Teper A; Insmed Incorporated, 700 US Highway 202/206, Bridgewater, NJ, 08807, USA.
Mange KC; Insmed Incorporated, 700 US Highway 202/206, Bridgewater, NJ, 08807, USA.
Perkins WR; Insmed Incorporated, 700 US Highway 202/206, Bridgewater, NJ, 08807, USA.
Sullivan EJ; Insmed Incorporated, 700 US Highway 202/206, Bridgewater, NJ, 08807, USA.
Pokaż więcej
Źródło:
Respiratory research [Respir Res] 2023 May 17; Vol. 24 (1), pp. 133. Date of Electronic Publication: 2023 May 17.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Salix*
Bronchiectasis*/diagnosis
Bronchiectasis*/drug therapy
Cystic Fibrosis*
Humans ; Serine Proteases/pharmacology ; Serine Proteases/therapeutic use ; Neutrophils ; Leukocyte Elastase ; Myeloblastin ; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases/pharmacology ; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Correction: The effect of COVID rehabilitation for ongoing symptoms Post HOSPitalisation with COVID-19 (PHOSP-R): protocol for a randomised parallel group controlled trial on behalf of the PHOSP consortium.
Autorzy:
Daynes E; NIHR Leicester Biomedical Research Centre-Respiratory, Leicester, UK. .; Department of Respiratory Sciences, University of Leicester, Leicester, UK. .
Baldwin M; NIHR Leicester Biomedical Research Centre-Respiratory, Leicester, UK.
Greening NJ; NIHR Leicester Biomedical Research Centre-Respiratory, Leicester, UK.; Department of Respiratory Sciences, University of Leicester, Leicester, UK.
Yates T; NIHR Leicester Biomedical Research Centre- Diabetes, Leicester, UK.; Diabetes Research Centre, College of Life Sciences, University of Leicester, Leicester, UK.
Bishop NC; National Centre for Sport and Exercise Medicine, School of Sport, Exercise and Health Sciences, Loughborough University, Loughborough, UK.
Mills G; NIHR Leicester Biomedical Research Centre-Respiratory, Leicester, UK.
Roberts M; NIHR Leicester Biomedical Research Centre-Respiratory, Leicester, UK.; National Centre for Sport and Exercise Medicine, School of Sport, Exercise and Health Sciences, Loughborough University, Loughborough, UK.
Hamrouni M; NIHR Leicester Biomedical Research Centre-Respiratory, Leicester, UK.; National Centre for Sport and Exercise Medicine, School of Sport, Exercise and Health Sciences, Loughborough University, Loughborough, UK.
Plekhanova T; NIHR Leicester Biomedical Research Centre- Diabetes, Leicester, UK.; Diabetes Research Centre, College of Life Sciences, University of Leicester, Leicester, UK.
Vogiatzis I; Faculty of Health and Life Sciences, Northumbria University Newcastle, Newcastle upon Tyne, UK.
Echevarria C; The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK.
Nathu R; NIHR Leicester Biomedical Research Centre-Respiratory, Leicester, UK.; Department of Respiratory Sciences, University of Leicester, Leicester, UK.
McAuley HJC; NIHR Leicester Biomedical Research Centre-Respiratory, Leicester, UK.; Department of Respiratory Sciences, University of Leicester, Leicester, UK.
Latimer L; NIHR Leicester Biomedical Research Centre-Respiratory, Leicester, UK.; Department of Respiratory Sciences, University of Leicester, Leicester, UK.
Glennie J; The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK.
Chambers F; The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK.
Penfold R; The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK.
Hume E; Faculty of Health and Life Sciences, Northumbria University Newcastle, Newcastle upon Tyne, UK.
Megaritis D; Faculty of Health and Life Sciences, Northumbria University Newcastle, Newcastle upon Tyne, UK.
Alexiou C; Faculty of Health and Life Sciences, Northumbria University Newcastle, Newcastle upon Tyne, UK.
Potthof S; Department of Social Work, Education, and Community Wellbeing, Northumbria University Newcastle, Newcastle upon Tyne, UK.
Hogg MJ; Faculty of Health and Life Sciences, Northumbria University Newcastle, Newcastle upon Tyne, UK.
Haighton C; Faculty of Health and Life Sciences, Northumbria University Newcastle, Newcastle upon Tyne, UK.
Nichol B; Faculty of Health and Life Sciences, Northumbria University Newcastle, Newcastle upon Tyne, UK.
Leavy OC; Department of Health Sciences, University of Leicester, Leicester, UK.
Richardson M; NIHR Leicester Biomedical Research Centre-Respiratory, Leicester, UK.
Elneima O; NIHR Leicester Biomedical Research Centre-Respiratory, Leicester, UK.; Department of Respiratory Sciences, University of Leicester, Leicester, UK.
Singapuri A; NIHR Leicester Biomedical Research Centre-Respiratory, Leicester, UK.; Department of Respiratory Sciences, University of Leicester, Leicester, UK.
Sereno M; NIHR Leicester Biomedical Research Centre-Respiratory, Leicester, UK.; Department of Respiratory Sciences, University of Leicester, Leicester, UK.
Saunders RM; NIHR Leicester Biomedical Research Centre-Respiratory, Leicester, UK.; Department of Respiratory Sciences, University of Leicester, Leicester, UK.
Harris VC; NIHR Leicester Biomedical Research Centre-Respiratory, Leicester, UK.
Nolan CM; College of Health, Medicine and Life Sciences, Brunel University, London, UK.; Harefield Respiratory Research Group, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Bolton C; School of Medicine, The University of Nottingham, Nottingham, UK.
Houchen-Wolloff L; NIHR Leicester Biomedical Research Centre-Respiratory, Leicester, UK.; Department of Respiratory Sciences, University of Leicester, Leicester, UK.
Harrison EM; Department of Health Sciences, University of Leicester, Leicester, UK.
Lone N; Centre for Medical Informatics, The Usher Institute, University of Edinburgh, Edinburgh, UK.; Usher Institute, University of Edinburgh, Edinburgh, UK.
Quint J; National Heart and Lung Institute, Imperial College London, London, UK.
Chalmers JD; Royal Infirmary of Edinburgh, NHS Lothian, Edinburgh, UK.
Ho LP; MRC Human Immunology Unit, University of Oxford, Oxford, UK.
Horsley A; Division of Infection, Immunity & Respiratory Medicine, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Marks M; Hospital for Tropical Diseases, University College London Hospitals, London, UK.; Division of Infection & Immunity, University College London, London, UK.
Poinasamy K; Asthma UK and British Lung Foundation, London, UK.
Ramen B; Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
Wain LV; NIHR Leicester Biomedical Research Centre-Respiratory, Leicester, UK.; Department of Health Sciences, University of Leicester, Leicester, UK.
Brightling C; NIHR Leicester Biomedical Research Centre-Respiratory, Leicester, UK.; Department of Respiratory Sciences, University of Leicester, Leicester, UK.
Man WD; Harefield Respiratory Research Group, Guy's and St Thomas' NHS Foundation Trust, London, UK.; University of Dundee, Ninewells Hospital and Medical School, Dundee, UK.; Harefield Respiratory Research Group, Heart, Lung and Critical Care Clinical Group, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Evans R; NIHR Leicester Biomedical Research Centre-Respiratory, Leicester, UK.; Department of Respiratory Sciences, University of Leicester, Leicester, UK.
Singh SJ; NIHR Leicester Biomedical Research Centre-Respiratory, Leicester, UK.; Department of Respiratory Sciences, University of Leicester, Leicester, UK.
Pokaż więcej
Źródło:
Trials [Trials] 2023 Feb 07; Vol. 24 (1), pp. 98. Date of Electronic Publication: 2023 Feb 07.
Typ publikacji:
Published Erratum
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The effect of COVID rehabilitation for ongoing symptoms Post HOSPitalisation with COVID-19 (PHOSP-R): protocol for a randomised parallel group controlled trial on behalf of the PHOSP consortium.
Autorzy:
Daynes E; NIHR Leicester Biomedical Research Centre-Respiratory, Leicester, UK. .; Department of Respiratory Sciences, University of Leicester, Leicester, UK. .
Baldwin M; NIHR Leicester Biomedical Research Centre-Respiratory, Leicester, UK.
Greening NJ; NIHR Leicester Biomedical Research Centre-Respiratory, Leicester, UK.; Department of Respiratory Sciences, University of Leicester, Leicester, UK.
Yates T; NIHR Leicester Biomedical Research Centre- Diabetes, Leicester, UK.; Diabetes Research Centre, College of Life Sciences, University of Leicester, Leicester, UK.
Bishop NC; National Centre for Sport and Exercise Medicine, School of Sport, Exercise and Health Sciences, Loughborough University, Loughborough, UK.
Mills G; NIHR Leicester Biomedical Research Centre-Respiratory, Leicester, UK.
Roberts M; NIHR Leicester Biomedical Research Centre-Respiratory, Leicester, UK.; National Centre for Sport and Exercise Medicine, School of Sport, Exercise and Health Sciences, Loughborough University, Loughborough, UK.
Hamrouni M; NIHR Leicester Biomedical Research Centre-Respiratory, Leicester, UK.; National Centre for Sport and Exercise Medicine, School of Sport, Exercise and Health Sciences, Loughborough University, Loughborough, UK.
Plekhanova T; NIHR Leicester Biomedical Research Centre- Diabetes, Leicester, UK.; Diabetes Research Centre, College of Life Sciences, University of Leicester, Leicester, UK.
Vogiatzis I; Faculty of Health and Life Sciences, Northumbria University Newcastle, Newcastle upon Tyne, UK.
Echevarria C; The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK.
Nathu R; NIHR Leicester Biomedical Research Centre-Respiratory, Leicester, UK.; Department of Respiratory Sciences, University of Leicester, Leicester, UK.
McAuley HJC; NIHR Leicester Biomedical Research Centre-Respiratory, Leicester, UK.; Department of Respiratory Sciences, University of Leicester, Leicester, UK.
Latimer L; NIHR Leicester Biomedical Research Centre-Respiratory, Leicester, UK.; Department of Respiratory Sciences, University of Leicester, Leicester, UK.
Glennie J; The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK.
Chambers F; The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK.
Penfold R; The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK.
Hume E; Faculty of Health and Life Sciences, Northumbria University Newcastle, Newcastle upon Tyne, UK.
Megaritis D; Faculty of Health and Life Sciences, Northumbria University Newcastle, Newcastle upon Tyne, UK.
Alexiou C; Faculty of Health and Life Sciences, Northumbria University Newcastle, Newcastle upon Tyne, UK.
Potthoff S; Department of Social Work, Education, and Community Wellbeing, Northumbria University Newcastle, Newcastle upon Tyne, UK.
Hogg MJ; Faculty of Health and Life Sciences, Northumbria University Newcastle, Newcastle upon Tyne, UK.
Haighton C; Faculty of Health and Life Sciences, Northumbria University Newcastle, Newcastle upon Tyne, UK.
Nichol B; Faculty of Health and Life Sciences, Northumbria University Newcastle, Newcastle upon Tyne, UK.
Leavy OC; Department of Health Sciences, University of Leicester, Leicester, UK.
Richardson M; NIHR Leicester Biomedical Research Centre-Respiratory, Leicester, UK.
Elneima O; NIHR Leicester Biomedical Research Centre-Respiratory, Leicester, UK.; Department of Respiratory Sciences, University of Leicester, Leicester, UK.
Singapuri A; NIHR Leicester Biomedical Research Centre-Respiratory, Leicester, UK.; Department of Respiratory Sciences, University of Leicester, Leicester, UK.
Sereno M; NIHR Leicester Biomedical Research Centre-Respiratory, Leicester, UK.; Department of Respiratory Sciences, University of Leicester, Leicester, UK.
Saunders RM; NIHR Leicester Biomedical Research Centre-Respiratory, Leicester, UK.; Department of Respiratory Sciences, University of Leicester, Leicester, UK.
Harris VC; NIHR Leicester Biomedical Research Centre-Respiratory, Leicester, UK.
Nolan CM; College of Health, Medicine and Life Sciences, Brunel University, London, UK.; Harefield Respiratory Research Group, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Bolton C; School of Medicine, The University of Nottingham, Nottingham, UK.
Houchen-Wolloff L; NIHR Leicester Biomedical Research Centre-Respiratory, Leicester, UK.; Department of Respiratory Sciences, University of Leicester, Leicester, UK.
Harrison EM; Department of Health Sciences, University of Leicester, Leicester, UK.
Lone N; Centre for Medical Informatics, The Usher Institute, University of Edinburgh, Edinburgh, UK.; Usher Institute, University of Edinburgh, Edinburgh, UK.
Quint J; National Heart and Lung Institute, Imperial College London, London, UK.
Chalmers JD; Royal Infirmary of Edinburgh, NHS Lothian, Edinburgh, UK.
Ho LP; MRC Human Immunology Unit, University of Oxford, Oxford, UK.
Horsley A; Division of Infection, Immunity & Respiratory Medicine, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Marks M; Hospital for Tropical Diseases, University College London Hospitals, London, UK.; Division of Infection & Immunity, University College London, London, UK.
Poinasamy K; Asthma UK and British Lung Foundation, London, UK.
Ramen B; Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
Wain LV; NIHR Leicester Biomedical Research Centre-Respiratory, Leicester, UK.; Department of Health Sciences, University of Leicester, Leicester, UK.
Brightling C; NIHR Leicester Biomedical Research Centre-Respiratory, Leicester, UK.; Department of Respiratory Sciences, University of Leicester, Leicester, UK.
Man WD; Harefield Respiratory Research Group, Guy's and St Thomas' NHS Foundation Trust, London, UK.; University of Dundee, Ninewells Hospital and Medical School, Dundee, UK.; Harefield Respiratory Research Group, Heart, Lung and Critical Care Clinical Group, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Evans R; NIHR Leicester Biomedical Research Centre-Respiratory, Leicester, UK.; Department of Respiratory Sciences, University of Leicester, Leicester, UK.
Singh SJ; NIHR Leicester Biomedical Research Centre-Respiratory, Leicester, UK.; Department of Respiratory Sciences, University of Leicester, Leicester, UK.
Pokaż więcej
Źródło:
Trials [Trials] 2023 Jan 26; Vol. 24 (1), pp. 61. Date of Electronic Publication: 2023 Jan 26.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
COVID-19*
Adult ; Humans ; Quality of Life ; Single-Blind Method ; Dyspnea ; Fatigue/diagnosis ; Fatigue/etiology ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Unmet needs in pneumonia research: a comprehensive approach by the CAPNETZ study group.
Autorzy:
Pletz MW; Institute of Infectious Diseases and Infection Control, Jena University Hospital - Friedrich Schiller University Jena, Jena, Germany.; CAPNETZ STIFTUNG, Hannover, Germany.
Jensen AV; Department of Pulmonary and Infectious Diseases, Nordsjællands Hospital, Hillerød, Denmark.
Bahrs C; Institute of Infectious Diseases and Infection Control, Jena University Hospital - Friedrich Schiller University Jena, Jena, Germany.; Division of Infectious Diseases and Tropical Medicine, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Davenport C; Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL), Hannover, Germany.
Rupp J; CAPNETZ STIFTUNG, Hannover, Germany.; Department of Infectious Diseases and Microbiology, University Hospital Schleswig-Holstein, German Center for Infection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems, Lübeck, Germany.
Witzenrath M; CAPNETZ STIFTUNG, Hannover, Germany.; Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.; Department of Pneumology, University Medical Center, Freiburg, Germany.
Barten-Neiner G; CAPNETZ STIFTUNG, Hannover, Germany.; Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL), Hannover, Germany.
Kolditz M; Division of Pulmonology, Medical Department I, University Hospital Carl Gustav Carus, Dresden, Germany.
Dettmer S; Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL), Hannover, Germany.; Department of Diagnostic and Interventional Radiology, Hannover Medical School, Hannover, Germany.
Chalmers JD; Scottish Centre for Respiratory Research, Ninewells Hospital and Medical School, University of Dundee, Dundee, DD1 9SY, UK.
Stolz D; Clinic of Respiratory Medicine and Pulmonary Cell Research, University Hospital, Basel, Switzerland.; Department of Pneumology, University Medical Center, Freiburg, Germany.
Suttorp N; Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.; German Center for Lung Research (DZL), Berlin, Germany.
Aliberti S; Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20072, Pieve Emanuele, Milan, Italy.; IRCCS Humanitas Research Hospital, Respiratory Unit, Via Manzoni 56, 20089, Rozzano, Milan, Italy.
Kuebler WM; Institute of Physiology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Rohde G; CAPNETZ STIFTUNG, Hannover, Germany. .; Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL), Hannover, Germany. .; Department of Respiratory Medicine, Medical Clinic I, University hospital, Goethe University Frankfurt, Theodor-Stern-Kai 7, 60596, Frankfurt/Main, Germany. .
Pokaż więcej
Źródło:
Respiratory research [Respir Res] 2022 Sep 10; Vol. 23 (1), pp. 239. Date of Electronic Publication: 2022 Sep 10.
Typ publikacji:
Journal Article; Review
MeSH Terms:
COVID-19*
Community-Acquired Infections*/diagnosis
Community-Acquired Infections*/epidemiology
Community-Acquired Infections*/therapy
Pneumonia*/diagnosis
Pneumonia*/epidemiology
Pneumonia*/therapy
Anti-Bacterial Agents/therapeutic use ; Europe/epidemiology ; Humans ; SARS-CoV-2
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Device-assessed sleep and physical activity in individuals recovering from a hospital admission for COVID-19: a multicentre study.
Autorzy:
Plekhanova T; Diabetes Research Centre, University of Leicester, Leicester General Hospital, Leicester, LE5 4PW, UK.; NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK.
Rowlands AV; Diabetes Research Centre, University of Leicester, Leicester General Hospital, Leicester, LE5 4PW, UK.; NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK.
Evans RA; NIHR Leicester Biomedical Research Centre, The Institute for Lung Health, University of Leicester, Leicester, UK.; University Hospitals of Leicester NHS Trust, Leicester, UK.
Edwardson CL; Diabetes Research Centre, University of Leicester, Leicester General Hospital, Leicester, LE5 4PW, UK. .; NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK. .
Bishop NC; School of Sport, Exercise and Health Sciences, Loughborough University, Loughborough, UK.
Bolton CE; University of Nottingham, Nottingham, UK.; Nottingham University Hospitals NHS Trust, Nottingham, UK.
Chalmers JD; University of Dundee, Ninewells Hospital and Medical School, Dundee, UK.
Davies MJ; Diabetes Research Centre, University of Leicester, Leicester General Hospital, Leicester, LE5 4PW, UK.; NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK.
Daynes E; NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK.; Department of Respiratory Sciences, University of Leicester, Leicester, UK.
Dempsey PC; Diabetes Research Centre, University of Leicester, Leicester General Hospital, Leicester, LE5 4PW, UK.
Docherty AB; Centre for Medical Informatics, The Usher Institute, University of Edinburgh, Edinburgh, UK.
Elneima O; NIHR Leicester Biomedical Research Centre, The Institute for Lung Health, University of Leicester, Leicester, UK.
Greening NJ; NIHR Leicester Biomedical Research Centre, The Institute for Lung Health, University of Leicester, Leicester, UK.
Greenwood SA; Department of Physiotherapy and Renal Medicine, King's College Hospital, London, UK.; Department of Renal Medicine, King's College London, London, UK.
Hall AP; University Hospitals of Leicester NHS Trust, Leicester, UK.; Department of Health Sciences, University of Leicester, Leicester, UK.
Harris VC; NIHR Leicester Biomedical Research Centre, The Institute for Lung Health, University of Leicester, Leicester, UK.; University Hospitals of Leicester NHS Trust, Leicester, UK.
Harrison EM; Centre for Medical Informatics, The Usher Institute, University of Edinburgh, Edinburgh, UK.
Henson J; Diabetes Research Centre, University of Leicester, Leicester General Hospital, Leicester, LE5 4PW, UK.; NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK.
Ho LP; MRC Human Immunology Unit, University of Oxford, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Horsley A; Division of Infection, Immunity & Respiratory Medicine, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.; Manchester University NHS Foundation Trust, Manchester, UK.
Houchen-Wolloff L; Department of Respiratory Sciences, University of Leicester, Leicester, UK.; Centre for Exercise and Rehabilitation Science, NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK.
Khunti K; Diabetes Research Centre, University of Leicester, Leicester General Hospital, Leicester, LE5 4PW, UK.; NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK.
Leavy OC; Department of Health Sciences, University of Leicester, Leicester, UK.
Lone NI; Centre for Medical Informatics, The Usher Institute, University of Edinburgh, Edinburgh, UK.; Royal Infirmary of Edinburgh, NHS Lothian, Edinburgh, UK.
Marks M; Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK.; Hospital for Tropical Diseases, University College London Hospital, London, UK.
Maylor B; Diabetes Research Centre, University of Leicester, Leicester General Hospital, Leicester, LE5 4PW, UK.; NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK.
McAuley HJC; NIHR Leicester Biomedical Research Centre, The Institute for Lung Health, University of Leicester, Leicester, UK.
Nolan CM; Harefield Respiratory Research Group, Royal Brompton and Harefield Clinical Group, Guy's and St, Thomas' NHS Foundation Trust, London, UK.; College of Health, Medicine and Life Sciences, Department of Health Sciences, Brunel University London, Uxbridge, UK.
Poinasamy K; Asthma UK and British Lung Foundation, London, UK.
Quint JK; NHLI, Imperial College London, London, UK.
Raman B; Radcliffe Department of Medicine, University of Oxford, Oxford, UK.; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Richardson M; NIHR Leicester Biomedical Research Centre, The Institute for Lung Health, University of Leicester, Leicester, UK.; College of Life Sciences, University of Leicester, Leicester, UK.
Sargeant JA; Diabetes Research Centre, University of Leicester, Leicester General Hospital, Leicester, LE5 4PW, UK.; NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK.
Saunders RM; NIHR Leicester Biomedical Research Centre, The Institute for Lung Health, University of Leicester, Leicester, UK.
Sereno M; NIHR Leicester Biomedical Research Centre, The Institute for Lung Health, University of Leicester, Leicester, UK.
Shikotra A; NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK.
Singapuri A; NIHR Leicester Biomedical Research Centre, The Institute for Lung Health, University of Leicester, Leicester, UK.
Steiner M; NIHR Leicester Biomedical Research Centre, The Institute for Lung Health, University of Leicester, Leicester, UK.; Department of Respiratory Sciences, University of Leicester, Leicester, UK.
Stensel DJ; NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK.; School of Sport, Exercise and Health Sciences, Loughborough University, Loughborough, UK.
Wain LV; NIHR Leicester Biomedical Research Centre, The Institute for Lung Health, University of Leicester, Leicester, UK.; Department of Health Sciences, University of Leicester, Leicester, UK.
Whitney J; School of Life Course & Population Sciences, King's College London, London, UK.; Department of Clinical Gerontology, King's College Hospital, London, UK.
Wootton DG; Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.; Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
Brightling CE; NIHR Leicester Biomedical Research Centre, The Institute for Lung Health, University of Leicester, Leicester, UK.
Man WD; Royal Brompton and Harefield Clinical Group, Guys and St Thomas NHS Foundation Trust, London, UK.; National Heart and Lung Institute, Imperial College London, London, UK.
Singh SJ; NIHR Leicester Biomedical Research Centre, The Institute for Lung Health, University of Leicester, Leicester, UK.
Yates T; Diabetes Research Centre, University of Leicester, Leicester General Hospital, Leicester, LE5 4PW, UK.; NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK.
Pokaż więcej
Corporate Authors:
Writing group (on behalf of the PHOSP-COVID Collaborative Group)
Źródło:
The international journal of behavioral nutrition and physical activity [Int J Behav Nutr Phys Act] 2022 Jul 28; Vol. 19 (1), pp. 94. Date of Electronic Publication: 2022 Jul 28.
Typ publikacji:
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:
COVID-19*
Diabetes Mellitus, Type 2*/therapy
Accelerometry/methods ; Aftercare ; Aged ; Exercise ; Female ; Hospitalization ; Hospitals ; Humans ; Male ; Patient Discharge ; Sleep
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
LTA4H rs2660845 association with montelukast response in early and late-onset asthma.
Autorzy:
Maroteau C; Centre for Genomics Research, Discovery Science, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom.; Division of Population Health and Genomics, School of Medicine, University of Dundee, Dundee, United Kingdom.
Espuela-Ortiz A; Genomics and Health Group, Department of Biochemistry, Microbiology, Cell Biology and Genetics, Universidad de La Laguna, San Cristobal de La Laguna, Santa Cruz de Tenerife, Spain.
Herrera-Luis E; Genomics and Health Group, Department of Biochemistry, Microbiology, Cell Biology and Genetics, Universidad de La Laguna, San Cristobal de La Laguna, Santa Cruz de Tenerife, Spain.
Srinivasan S; Division of Population Health and Genomics, School of Medicine, University of Dundee, Dundee, United Kingdom.
Carr F; Division of Population Health and Genomics, School of Medicine, University of Dundee, Dundee, United Kingdom.
Tavendale R; Division of Population Health and Genomics, School of Medicine, University of Dundee, Dundee, United Kingdom.
Wilson K; Division of Population Health and Genomics, School of Medicine, University of Dundee, Dundee, United Kingdom.
Hernandez-Pacheco N; Genomics and Health Group, Department of Biochemistry, Microbiology, Cell Biology and Genetics, Universidad de La Laguna, San Cristobal de La Laguna, Santa Cruz de Tenerife, Spain.; Research Unit, Hospital Universitario N.S. de Candelaria, Universidad de La Laguna, San Cristobal de La Laguna, Spain.
Chalmers JD; Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, Dundee, United Kingdom.
Turner S; Child Health, University of Aberdeen, Aberdeen, United Kingdom.
Mukhopadhyay S; Academic Department of Pediatrics, Brighton and Sussex Medical School, Royal Alexandra Children's Hospital, Brighton, United Kingdom.
Maitland-van der Zee AH; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands.; Department of Respiratory Medicine, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.; Department of Pediatric Respiratory Medicine and Allergy, Emma's Children Hospital, Academic Medical Center (AMC), University of Amsterdam, Amsterdam, The Netherlands.
Burchard EG; Department of Medicine, University of California San Francisco, San Francisco, California, United States of America.; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California, United States of America.
Pino-Yanes M; Genomics and Health Group, Department of Biochemistry, Microbiology, Cell Biology and Genetics, Universidad de La Laguna, San Cristobal de La Laguna, Santa Cruz de Tenerife, Spain.; CIBER de Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Comunidad de Madrid, Spain.; Instituto de Tecnologías Biomédicas (ITB), Universidad de La Laguna, San Cristóbal de La Laguna, Santa Cruz de Tenerife, Spain.
Young S; BioPharmaceutical Precision Medicine, Oncology R&D, AstraZeneca, Cambridge, United Kingdom.; Research & Development Centre, Sysmex, Cambridge, United Kingdom.
Lassi G; Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom.
Platt A; Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom.
Palmer CNA; Division of Population Health and Genomics, School of Medicine, University of Dundee, Dundee, United Kingdom.
Pokaż więcej
Corporate Authors:
PiCA Consortium
Źródło:
PloS one [PLoS One] 2021 Sep 22; Vol. 16 (9), pp. e0257396. Date of Electronic Publication: 2021 Sep 22 (Print Publication: 2021).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Pharmacogenetics*
Acetates/*therapeutic use
Asthma/*drug therapy
Cyclopropanes/*therapeutic use
Epoxide Hydrolases/*genetics
Quinolines/*therapeutic use
Sulfides/*therapeutic use
Adolescent ; Adult ; Age of Onset ; Alleles ; Anti-Asthmatic Agents/therapeutic use ; Asthma/physiopathology ; Child ; Child, Preschool ; Cross-Sectional Studies ; Europe ; Female ; Genotype ; Hospitalization ; Humans ; Leukotriene Antagonists/therapeutic use ; Longitudinal Studies ; Male ; Middle Aged ; Odds Ratio ; Regression Analysis ; Risk ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Maximizing Adherence and Gaining New Information For Your Chronic Obstructive Pulmonary Disease (MAGNIFY COPD): Study Protocol for the Pragmatic, Cluster Randomized Trial Evaluating the Impact of Dual Bronchodilator with Add-On Sensor and Electronic Monitoring on Clinical Outcomes.
Autorzy:
Price D; Observational and Pragmatic Research Institute, Singapore, Singapore.; Centre of Academic Primary Care, Division of Applied Health Sciences, University of Aberdeen, Aberdeen, UK.
Jones R; Faculty of Health, University of Plymouth, Plymouth, Devon, UK.
Pfister P; Novartis Pharma AG, Basel, Switzerland.
Cao H; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
Carter V; Observational and Pragmatic Research International Ltd, Stubbs House Stubbs Green, London, Norwich, UK.
Kemppinen A; Observational and Pragmatic Research International Ltd, Stubbs House Stubbs Green, London, Norwich, UK.
Holzhauer B; Novartis Pharma AG, Basel, Switzerland.
Kaplan A; Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada.
Clark A; Norwich Medical School, University of East Anglia, Norwich, UK.
Halpin DMG; University of Exeter Medical School, College of Medicine and Health, University of Exeter, Exeter, UK.
Pinnock H; Allergy and Respiratory Research Group, Usher Institute, University of Edinburgh, Edinburgh, UK.
Chalmers JD; College of Medicine, University of Dundee, Dundee, UK.
van Boven JFM; Department of Clinical Pharmacy & Pharmacology, Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Beeh KM; Clinical Research, Insaf Respiratory Research Institute, Wiesbaden, Germany.
Kostikas K; Respiratory Medicine Department, University of Ioannina School of Medicine, Ioannina, Greece.
Roche N; Cochin Hospital and Institute, APHP Centre, University of Paris, Paris, France.
Usmani O; National Heart & Lung Institute (NHLI), Imperial College London and Royal Brompton Hospital, London, UK.
Mastoridis P; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
Pokaż więcej
Źródło:
Pragmatic and observational research [Pragmat Obs Res] 2021 May 24; Vol. 12, pp. 25-35. Date of Electronic Publication: 2021 May 24 (Print Publication: 2021).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Genetic and pharmacological relationship between P-glycoprotein and increased cardiovascular risk associated with clarithromycin prescription: An epidemiological and genomic population-based cohort study in Scotland, UK.
Autorzy:
Mordi IR; Division of Molecular and Clinical Medicine, University of Dundee, Dundee, United Kingdom.
Chan BK; School of Public Health, Oregon Health and Science University and Portland State University, Portland, Oregon, United States of America.
Yanez ND; School of Public Health, Oregon Health and Science University and Portland State University, Portland, Oregon, United States of America.
Palmer CNA; Division of Population Health and Genomics, University of Dundee, Dundee, United Kingdom.
Lang CC; Division of Molecular and Clinical Medicine, University of Dundee, Dundee, United Kingdom.
Chalmers JD; Division of Molecular and Clinical Medicine, University of Dundee, Dundee, United Kingdom.
Pokaż więcej
Źródło:
PLoS medicine [PLoS Med] 2020 Nov 23; Vol. 17 (11), pp. e1003372. Date of Electronic Publication: 2020 Nov 23 (Print Publication: 2020).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
ATP Binding Cassette Transporter, Subfamily B, Member 1*/adverse effects
ATP Binding Cassette Transporter, Subfamily B, Member 1*/metabolism
Cardiovascular Diseases*/chemically induced
Cardiovascular Diseases*/drug therapy
Cardiovascular Diseases*/genetics
Clarithromycin*/adverse effects
Clarithromycin*/therapeutic use
Prescriptions/*statistics & numerical data
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Anti-Bacterial Agents/adverse effects ; Anti-Bacterial Agents/therapeutic use ; Cohort Studies ; Diabetes Mellitus, Type 2/chemically induced ; Diabetes Mellitus, Type 2/complications ; Female ; Genomics ; Heart Disease Risk Factors ; Humans ; Male ; Middle Aged ; Scotland ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trials.
Autorzy:
Singh D; Medicines Evaluation Unit, University of Manchester, Manchester University NHS Foundation Trust, Manchester, UK. .
Wedzicha JA; Respiratory Division, National Heart and Lung Institute, Imperial College London, London, UK.
Siddiqui S; NIHR Leicester Biomedical Research Centre: Respiratory Theme, and Department of Respiratory Sciences, University of Leicester, Leicester, UK.
de la Hoz A; Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany.
Xue W; Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA.
Magnussen H; Pulmonary Research Institute at Lung Clinic Grosshansdorf, Grosshansdorf, Germany.
Miravitlles M; Pneumology Department, Hospital Universitari Vall d'Hebron/Vall d'Hebron Research Institute (VHIR), CIBER de Enfermedades Respiratorias (CIBERES), Barcelona, Spain.
Chalmers JD; Scottish Centre for Respiratory Research, University of Dundee, Ninewells Hospital and Medical School, Dundee, UK.
Calverley PMA; Clinical Science Centre, Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, UK.
Pokaż więcej
Źródło:
Respiratory research [Respir Res] 2020 Sep 17; Vol. 21 (1), pp. 240. Date of Electronic Publication: 2020 Sep 17.
Typ publikacji:
Journal Article; Meta-Analysis
MeSH Terms:
Clinical Trials, Phase III as Topic/*methods
Clinical Trials, Phase IV as Topic/*methods
Eosinophils/*metabolism
Pulmonary Disease, Chronic Obstructive/*blood
Pulmonary Disease, Chronic Obstructive/*diagnosis
Biomarkers/blood ; Forecasting ; Humans ; Multicenter Studies as Topic/methods ; Pulmonary Disease, Chronic Obstructive/epidemiology ; Risk Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Blood neutrophil counts are associated with exacerbation frequency and mortality in COPD.
Autorzy:
Lonergan M; Scottish Centre for Respiratory Research, University of Dundee, Ninewells Hospital and Medical School, Dundee, DD1 9SY, UK.
Dicker AJ; Scottish Centre for Respiratory Research, University of Dundee, Ninewells Hospital and Medical School, Dundee, DD1 9SY, UK.
Crichton ML; Scottish Centre for Respiratory Research, University of Dundee, Ninewells Hospital and Medical School, Dundee, DD1 9SY, UK.
Keir HR; Scottish Centre for Respiratory Research, University of Dundee, Ninewells Hospital and Medical School, Dundee, DD1 9SY, UK.
Van Dyke MK; Epidemiology, Value Evidence and Outcomes, GSK R&D, Collegeville, PA, USA.
Mullerova H; Epidemiology, Value Evidence and Outcomes, GSK R&D, Uxbridge, UK.
Miller BE; Medical Innovation, Value Evidence and Outcomes, GSK R&D, Collegeville, PA, USA.
Tal-Singer R; Medical Innovation, Value Evidence and Outcomes, GSK R&D, Collegeville, PA, USA.
Chalmers JD; Scottish Centre for Respiratory Research, University of Dundee, Ninewells Hospital and Medical School, Dundee, DD1 9SY, UK. .
Pokaż więcej
Źródło:
Respiratory research [Respir Res] 2020 Jul 01; Vol. 21 (1), pp. 166. Date of Electronic Publication: 2020 Jul 01.
Typ publikacji:
Journal Article
MeSH Terms:
Leukocyte Count*
Neutrophils*
Pulmonary Disease, Chronic Obstructive/*blood
Pulmonary Disease, Chronic Obstructive/*mortality
Aged ; Aged, 80 and over ; Eosinophils ; Female ; Humans ; Male ; Microbiota ; Middle Aged ; Predictive Value of Tests ; Pulmonary Disease, Chronic Obstructive/complications ; Registries ; Scotland/epidemiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Development and initial validation of the bronchiectasis exacerbation and symptom tool (BEST).
Autorzy:
Artaraz A; Department of Respiratory Medicine, Galdakao-Usansolo Hospital, Galdakao, Bizkaia, Spain.
Crichton ML; Scottish Centre for Respiratory Research, Ninewells Hospital and Medical School, Division of Molecular and Clinical Medicine, University of Dundee, DD1 9SY, Dundee, Scotland.
Finch S; Scottish Centre for Respiratory Research, Ninewells Hospital and Medical School, Division of Molecular and Clinical Medicine, University of Dundee, DD1 9SY, Dundee, Scotland.
Abo-Leyah H; Scottish Centre for Respiratory Research, Ninewells Hospital and Medical School, Division of Molecular and Clinical Medicine, University of Dundee, DD1 9SY, Dundee, Scotland.
Goeminne P; AZ Nikolaas, Sint-Niklaas, Belgium.
Aliberti S; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Respiratory Unit and Cystic Fibrosis Adult Center, Milan, Italy.
Fardon T; Scottish Centre for Respiratory Research, Ninewells Hospital and Medical School, Division of Molecular and Clinical Medicine, University of Dundee, DD1 9SY, Dundee, Scotland.
Chalmers JD; Scottish Centre for Respiratory Research, Ninewells Hospital and Medical School, Division of Molecular and Clinical Medicine, University of Dundee, DD1 9SY, Dundee, Scotland. .
Pokaż więcej
Źródło:
Respiratory research [Respir Res] 2020 Jan 13; Vol. 21 (1), pp. 18. Date of Electronic Publication: 2020 Jan 13.
Typ publikacji:
Journal Article; Multicenter Study; Observational Study
MeSH Terms:
Disease Progression*
Severity of Illness Index*
Bronchiectasis/*diagnosis
Medical Records/*standards
Aged ; Bronchiectasis/physiopathology ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Pilot Projects ; Prospective Studies ; Reproducibility of Results
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Assessment of Phenotype Microarray plates for rapid and high-throughput analysis of collateral sensitivity networks.
Autorzy:
Dunkley EJ; Centre for Biodiscovery, School of Biological Sciences, Victoria University, Wellington, New Zealand.
Chalmers JD; Department of Biochemistry, University of Otago, Dunedin, New Zealand.
Cho S; Department of Biochemistry, University of Otago, Dunedin, New Zealand.
Finn TJ; Department of Biochemistry, University of Otago, Dunedin, New Zealand.
Patrick WM; Centre for Biodiscovery, School of Biological Sciences, Victoria University, Wellington, New Zealand.; Department of Biochemistry, University of Otago, Dunedin, New Zealand.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2019 Dec 18; Vol. 14 (12), pp. e0219879. Date of Electronic Publication: 2019 Dec 18 (Print Publication: 2019).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Adaptation, Physiological/*drug effects
Anti-Bacterial Agents/*pharmacology
Drug Collateral Sensitivity/*drug effects
Staphylococcal Infections/*drug therapy
Staphylococcus aureus/*drug effects
Staphylococcus aureus/*growth & development
Humans ; Microbial Sensitivity Tests ; Phenotype ; Staphylococcal Infections/microbiology ; Staphylococcus aureus/isolation & purification
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Single-inhaler triple therapy in patients with chronic obstructive pulmonary disease: a systematic review.
Autorzy:
Langham S; Maverex Limited, Manchester, UK. .
Lewis J; Maverex Limited, Manchester, UK.
Pooley N; Maverex Limited, Manchester, UK.
Embleton N; Maverex Limited, Manchester, UK.
Langham J; Maverex Limited, Manchester, UK.
Han MK; University of Michigan, Women's Respiratory Clinic, Ann Arbor, USA.
Chalmers JD; University of Dundee and Ninewells Hospital and Medical School, Dundee, UK.
Pokaż więcej
Źródło:
Respiratory research [Respir Res] 2019 Nov 04; Vol. 20 (1), pp. 242. Date of Electronic Publication: 2019 Nov 04.
Typ publikacji:
Journal Article; Systematic Review
MeSH Terms:
Adrenal Cortex Hormones/*administration & dosage
Adrenergic beta-2 Receptor Agonists/*administration & dosage
Bronchodilator Agents/*administration & dosage
Lung/*drug effects
Muscarinic Antagonists/*administration & dosage
Pulmonary Disease, Chronic Obstructive/*drug therapy
Administration, Inhalation ; Adrenal Cortex Hormones/adverse effects ; Adrenergic beta-2 Receptor Agonists/adverse effects ; Aged ; Bronchodilator Agents/adverse effects ; Disease Progression ; Drug Therapy, Combination ; Female ; Humans ; Lung/physiopathology ; Male ; Middle Aged ; Muscarinic Antagonists/adverse effects ; Nebulizers and Vaporizers ; Pulmonary Disease, Chronic Obstructive/diagnosis ; Pulmonary Disease, Chronic Obstructive/physiopathology ; Randomized Controlled Trials as Topic ; Recovery of Function ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The effect of changes to GOLD severity stage on long term morbidity and mortality in COPD.
Autorzy:
Flynn RWV; Division of Molecular and Clinical Medicine, University of Dundee, Ninewells Hospital & Medical School, Dundee, DD1 9SY, UK. .
MacDonald TM; Division of Molecular and Clinical Medicine, University of Dundee, Ninewells Hospital & Medical School, Dundee, DD1 9SY, UK.
Chalmers JD; Division of Molecular and Clinical Medicine, University of Dundee, Ninewells Hospital & Medical School, Dundee, DD1 9SY, UK.
Schembri S; Division of Molecular and Clinical Medicine, University of Dundee, Ninewells Hospital & Medical School, Dundee, DD1 9SY, UK.
Pokaż więcej
Źródło:
Respiratory research [Respir Res] 2018 Dec 12; Vol. 19 (1), pp. 249. Date of Electronic Publication: 2018 Dec 12.
Typ publikacji:
Journal Article; Observational Study
MeSH Terms:
Severity of Illness Index*
Global Health/*trends
Pulmonary Disease, Chronic Obstructive/*diagnosis
Pulmonary Disease, Chronic Obstructive/*mortality
Aged ; Cohort Studies ; Female ; Follow-Up Studies ; Forced Expiratory Volume/physiology ; Humans ; Longitudinal Studies ; Male ; Middle Aged ; Morbidity/trends ; Mortality/trends ; Pulmonary Disease, Chronic Obstructive/physiopathology ; Respiratory Function Tests/mortality ; Respiratory Function Tests/trends ; Scotland/epidemiology ; Spirometry/mortality ; Spirometry/trends
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
How to Process Sputum Samples and Extract Bacterial DNA for Microbiota Analysis.
Autorzy:
Terranova L; Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Pediatric Highly Intensive Care Unit, 20100 Milan, Italy. .; Department of Clinical Sciences and Community Health, University of Milan, 20100 Milan, Italy. .
Oriano M; Department of Pathophysiology and Transplantation, University of Milan, Internal Medicine Department, Respiratory unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20100 Milan, Italy. .; Department of Molecular Medicine, University of Pavia, 27100 Pavia, Italy. .
Teri A; Cystic Fibrosis Microbiology Laboratory, Fondazione IRCCS Ca' Granda, 20100 Milan, Italy. .
Ruggiero L; Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Pediatric Highly Intensive Care Unit, 20100 Milan, Italy. .
Tafuro C; Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Pediatric Highly Intensive Care Unit, 20100 Milan, Italy. .
Marchisio P; Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Pediatric Highly Intensive Care Unit, 20100 Milan, Italy. .
Gramegna A; Department of Pathophysiology and Transplantation, University of Milan, Internal Medicine Department, Respiratory unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20100 Milan, Italy. .
Contarini M; Department of Pathophysiology and Transplantation, University of Milan, Internal Medicine Department, Respiratory unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20100 Milan, Italy. .
Franceschi E; Department of Pathophysiology and Transplantation, University of Milan, Internal Medicine Department, Respiratory unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20100 Milan, Italy. .
Sottotetti S; Cystic Fibrosis Microbiology Laboratory, Fondazione IRCCS Ca' Granda, 20100 Milan, Italy. .
Cariani L; Cystic Fibrosis Microbiology Laboratory, Fondazione IRCCS Ca' Granda, 20100 Milan, Italy. .
Bevivino A; Department for Sustainability, Italian National Agency for New Technologies, Energy and Sustainable Economic Development (ENEA), 00123 Rome, Italy. .
Chalmers JD; Scottish Centre for Respiratory Research, University of Dundee, Ninewells Hospital and Medical School, DD1 9SY Dundee, UK. j.chalmers@dundee.ac.uk.
Aliberti S; Department of Pathophysiology and Transplantation, University of Milan, Internal Medicine Department, Respiratory unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20100 Milan, Italy. .
Blasi F; Department of Pathophysiology and Transplantation, University of Milan, Internal Medicine Department, Respiratory unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20100 Milan, Italy. .
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2018 Oct 20; Vol. 19 (10). Date of Electronic Publication: 2018 Oct 20.
Typ publikacji:
Journal Article
MeSH Terms:
Microbiota*
DNA, Bacterial/*chemistry
Molecular Diagnostic Techniques/*methods
Sequence Analysis, DNA/*methods
Sputum/*microbiology
Adult ; DNA, Bacterial/genetics ; Humans ; RNA, Ribosomal, 16S/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The future of accreditation of continuing medical education (CME)-continuing professional development (CPD) in Europe: harmonisation through dialogue and consensus.
Autorzy:
de Andrade F; Continuing Medical Education - European Accreditors (CME-EA) Registered Association, Cologne, Germany.
Griebenow R; Continuing Medical Education - European Accreditors (CME-EA) Registered Association, Cologne, Germany.
Costello RW; Continuing Medical Education - European Accreditors (CME-EA) Registered Association, Cologne, Germany.
Guenova M; Continuing Medical Education - European Accreditors (CME-EA) Registered Association, Cologne, Germany.
Schaefer R; Continuing Medical Education - European Accreditors (CME-EA) Registered Association, Cologne, Germany.
Chalmers JD; Continuing Medical Education - European Accreditors (CME-EA) Registered Association, Cologne, Germany.
Tichelli A; Continuing Medical Education - European Accreditors (CME-EA) Registered Association, Cologne, Germany.
Raguz D; Continuing Medical Education - European Accreditors (CME-EA) Registered Association, Cologne, Germany.
Stein J; Continuing Medical Education - European Accreditors (CME-EA) Registered Association, Cologne, Germany.
Pokaż więcej
Źródło:
Journal of European CME [J Eur CME] 2018 Sep 03; Vol. 7 (1), pp. 1506202. Date of Electronic Publication: 2018 Sep 03 (Print Publication: 2018).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Why, when and how to investigate primary ciliary dyskinesia in adult patients with bronchiectasis.
Autorzy:
Contarini M; Department of Pathophysiology and Transplantation, University of Milan, Internal Medicine Department, Respiratory unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122 Milan, Italy.
Shoemark A; Division of Molecular and Clinical Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee, UK.
Rademacher J; Department of Respiratory Medicine, Hannover Medical School and German Center for Lung Research (DZL), Hannover, Germany.
Finch S; Division of Molecular and Clinical Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee, UK.
Gramegna A; Department of Pathophysiology and Transplantation, University of Milan, Internal Medicine Department, Respiratory unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122 Milan, Italy.
Gaffuri M; 4Department of Otolaryngology and Head and Neck Surgery, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
Roncoroni L; 4Department of Otolaryngology and Head and Neck Surgery, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
Seia M; 5Medical Genetics Laboratory, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Ringshausen FC; Department of Respiratory Medicine, Hannover Medical School and German Center for Lung Research (DZL), Hannover, Germany.
Welte T; Department of Respiratory Medicine, Hannover Medical School and German Center for Lung Research (DZL), Hannover, Germany.
Blasi F; Department of Pathophysiology and Transplantation, University of Milan, Internal Medicine Department, Respiratory unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122 Milan, Italy.
Aliberti S; Department of Pathophysiology and Transplantation, University of Milan, Internal Medicine Department, Respiratory unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122 Milan, Italy.
Chalmers JD; Division of Molecular and Clinical Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee, UK.
Pokaż więcej
Źródło:
Multidisciplinary respiratory medicine [Multidiscip Respir Med] 2018 Aug 09; Vol. 13 (Suppl 1), pp. 26. Date of Electronic Publication: 2018 Aug 09 (Print Publication: 2018).
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Get together to increase awareness in bronchiectasis: a report of the 2 World Bronchiectasis Conference.
Autorzy:
Aliberti S; Department of Pathophysiology and Transplantation, University of Milan, Internal Medicine Department, Respiratory Unit and Cystic Fibrosis Adult Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122 Milan, Italy.
Chalmers JD; 2Tayside Respiratory Research Group, University of Dundee, Dundee, DD1 9SY UK.
Pokaż więcej
Źródło:
Multidisciplinary respiratory medicine [Multidiscip Respir Med] 2018 Aug 09; Vol. 13 (Suppl 1), pp. 28. Date of Electronic Publication: 2018 Aug 09 (Print Publication: 2018).
Typ publikacji:
Editorial
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Assessing the healthcare resource use associated with inappropriate prescribing of inhaled corticosteroids for people with chronic obstructive pulmonary disease (COPD) in GOLD groups A or B: an observational study using the Clinical Practice Research Datalink (CPRD).
Autorzy:
Chalmers JD; Scottish Centre for Respiratory Research, University of Dundee, Ninewells Hospital and Medical School, Dundee, UK.
Poole C; Boehringer Ingelheim Ltd, Bracknell, UK.
Webster S; Boehringer Ingelheim Ltd, Bracknell, UK. .
Tebboth A; Boehringer Ingelheim Ltd, Bracknell, UK.
Dickinson S; Boehringer Ingelheim Ltd, Bracknell, UK.
Gayle A; Boehringer Ingelheim Ltd, Bracknell, UK.
Pokaż więcej
Źródło:
Respiratory research [Respir Res] 2018 Apr 11; Vol. 19 (1), pp. 63. Date of Electronic Publication: 2018 Apr 11.
Typ publikacji:
Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Databases, Factual*/trends
Inappropriate Prescribing*/trends
Patient Acceptance of Health Care*
Adrenal Cortex Hormones/*administration & dosage
Bronchodilator Agents/*administration & dosage
Pulmonary Disease, Chronic Obstructive/*drug therapy
Administration, Inhalation ; Adult ; Aged ; Aged, 80 and over ; Cohort Studies ; Female ; Humans ; Longitudinal Studies ; Male ; Middle Aged ; Practice Patterns, Physicians'/trends ; Pulmonary Disease, Chronic Obstructive/epidemiology ; United Kingdom/epidemiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 33

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies